Related Experiment Video

Updated: Dec 30, 2025

Time-resolved Förster Resonance Energy Transfer Assays for Measurement of Endogenous Phosphorylated STAT Proteins in Human Cells
07:12

Time-resolved Förster Resonance Energy Transfer Assays for Measurement of Endogenous Phosphorylated STAT Proteins in Human Cells

Published on: September 9, 2021

4.1K

The role of JAK/STAT signaling pathway and its inhibitors in diseases

Ping Xin1, Xiaoyun Xu1, Chengjie Deng1

  • 1College of Pharmacy, Harbin Medical University-Daqing, Daqing 163319, China.

International Immunopharmacology
|January 24, 2020
PubMed

Insights

The Janus kinase/signal transducer and activator of transcription (JAK/STAT) pathway regulates cell functions but its persistent activation links to immune diseases. Understanding JAK/STAT signaling mechanisms is crucial for developing effective therapies.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Immunology

Background:

  • The Janus kinase/signal transducer and activator of transcription (JAK/STAT) pathway is a key intracellular signaling system.
  • It regulates critical cellular processes like proliferation, differentiation, apoptosis, and immune responses.
  • Dysregulation of this pathway is implicated in various immune and inflammatory diseases.

Purpose of the Study:

  • To review the structure of JAKs and STATs.
  • To elucidate the JAK/STAT signaling pathway, its negative regulation, and associated diseases.
  • To discuss Janus kinase (JAK) inhibitors for clinical therapy.

Main Methods:

  • Literature review of JAK/STAT signaling pathway.
  • Analysis of pathway crosstalk and its role in disease.
  • Compilation of information on JAK inhibitors.

Main Results:

  • The JAK/STAT pathway, while simple in mechanism, has complex biological outcomes due to pathway crosstalk.
  • Persistent activation of JAK/STAT signaling is increasingly linked to immune and inflammatory diseases.
  • JAK inhibitors show potential for clinical treatment of associated diseases.

Conclusions:

  • Further research into the detailed mechanisms of JAK/STAT signaling in disease pathogenesis is essential.
  • Understanding these mechanisms will provide critical insights for clinical treatments.
  • JAK inhibitors represent a promising therapeutic strategy for diseases involving JAK/STAT pathway dysregulation.
Keywords:
JAK/STAT pathway and diseasesJAK/STAT signaling pathwayJAKs inhibitors and diseasesNegative regulators

More Related Videos

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model08:15

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model

Published on: June 6, 2025

464
Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma10:21

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma

Published on: September 20, 2024

688

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
11.6K
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
16.8K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.1K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.7K